source
- City Therapeutics completes $200 million IPO, earmarks funds for RNAi therapiesCity Therapeutics, based in Cambridge, Massachusetts, launched an IPO raising $200 million, exceeding its original target of 9.7 million shares at $17-$19 per share. The company sold 11.1 million…
- HHS moves to let compounding pharmacies make select peptides as China tightens biotech exports but permits foreign licensingThe HHS announced a policy that would allow compounding pharmacies to produce certain peptide drugs, expanding access and potentially lowering costs. The move is part of the Trump administration's…